DD210451A1 - Verfahren zur herstellung von imidazolderivaten - Google Patents

Verfahren zur herstellung von imidazolderivaten Download PDF

Info

Publication number
DD210451A1
DD210451A1 DD82236974A DD23697482A DD210451A1 DD 210451 A1 DD210451 A1 DD 210451A1 DD 82236974 A DD82236974 A DD 82236974A DD 23697482 A DD23697482 A DD 23697482A DD 210451 A1 DD210451 A1 DD 210451A1
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
hydrogen
give
group
Prior art date
Application number
DD82236974A
Other languages
German (de)
English (en)
Inventor
Arto J Karjalainen
Kauko O A Kurkela
Seppo S L Parhi
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of DD210451A1 publication Critical patent/DD210451A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Catalysts (AREA)
DD82236974A 1981-02-05 1982-01-26 Verfahren zur herstellung von imidazolderivaten DD210451A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8103620A GB2092569B (en) 1981-02-05 1981-02-05 Substituted imidazole derivatives and their preparation and use

Publications (1)

Publication Number Publication Date
DD210451A1 true DD210451A1 (de) 1984-06-13

Family

ID=10519480

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82236974A DD210451A1 (de) 1981-02-05 1982-01-26 Verfahren zur herstellung von imidazolderivaten

Country Status (18)

Country Link
US (2) US4514412A (fr)
EP (1) EP0058047B1 (fr)
JP (1) JPS57149273A (fr)
AT (1) ATE10192T1 (fr)
AU (1) AU552322B2 (fr)
CA (1) CA1176259A (fr)
DD (1) DD210451A1 (fr)
DE (1) DE3261153D1 (fr)
DK (2) DK157545C (fr)
FI (1) FI76568C (fr)
GB (1) GB2092569B (fr)
HU (1) HU187564B (fr)
IE (1) IE52362B1 (fr)
IL (1) IL64922A (fr)
NO (1) NO155884C (fr)
NZ (1) NZ199631A (fr)
SU (1) SU1162372A3 (fr)
ZA (1) ZA82717B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI833794A0 (fi) * 1983-10-18 1983-10-18 Farmos Oy Substituerade 2-merkapto-imidazoler
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
GB8523255D0 (en) * 1985-09-20 1985-10-23 Shell Int Research Imidazoles
GB8626287D0 (en) * 1986-11-04 1986-12-03 Ucb Sa Substituted 1h-imidazoles
JPS63150266A (ja) * 1986-12-12 1988-06-22 Mitsui Petrochem Ind Ltd ベンジルイミダゾ−ル誘導体
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2210875B (en) * 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
GB8810067D0 (en) 1988-04-28 1988-06-02 Ucb Sa Substituted 1-(1h-imidazol-4-yl)alkyl-benzamides
AU627559B2 (en) * 1989-03-30 1992-08-27 Farmos-Yhtyma Oy Novel aromatase inhibiting 4(5)-imidazoles
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions
US6841684B2 (en) 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
KR20050114641A (ko) * 2003-03-07 2005-12-06 아스텔라스세이야쿠 가부시키가이샤 2,6-이치환된 스티릴을 갖는 질소 함유 헤테로환 유도체
JP5025266B2 (ja) * 2004-09-01 2012-09-12 アステラス製薬株式会社 ピペリジン誘導体又はその製薬学的に許容される塩
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
EP2847173B1 (fr) 2012-05-08 2015-12-30 Lonza Ltd Procédé de préparation de médétomidine
PL2847157T3 (pl) 2012-05-08 2016-04-29 Lonza Ag Sposób wytwarzania 2-(2,3-dimetylofenylo)-1-propanalu
WO2012172119A2 (fr) * 2012-05-08 2012-12-20 Lonza Ltd Procédé de préparation de médétomidine
CN104245678B (zh) 2012-06-28 2016-02-24 隆萨有限公司 用氯丙酮制备美托咪定的方法
KR101537203B1 (ko) 2012-06-28 2015-07-22 론자 아게 (론자 엘티디.) 2-(2,3-디메틸페닐)-1-프로파날의 클로로아세톤으로의 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3356645A (en) * 1964-04-20 1967-12-05 Shell Oil Co Process for curing epoxy resins with a salt of an imidazole and compositions thereof
FR2122395A1 (en) * 1971-01-19 1972-09-01 Berlin Chemie Veb Pharmacologically active imidazoles - by condensing alpha-aminoketones with formamide
DD96070A1 (fr) * 1971-02-23 1973-03-12
JPS54148788A (en) * 1978-05-15 1979-11-21 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative and its preparation
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
JPS624387A (ja) * 1985-07-01 1987-01-10 日本電気株式会社 プリント回路基板

Also Published As

Publication number Publication date
IE820241L (en) 1982-08-05
IL64922A (en) 1986-01-31
NZ199631A (en) 1985-02-28
DE3261153D1 (en) 1984-12-13
DK158351C (da) 1990-10-08
DK44682A (da) 1982-08-06
AU552322B2 (en) 1986-05-29
GB2092569A (en) 1982-08-18
SU1162372A3 (ru) 1985-06-15
IE52362B1 (en) 1987-09-30
DK157545B (da) 1990-01-22
US4514412A (en) 1985-04-30
DK157545C (da) 1990-06-11
ZA82717B (en) 1983-01-26
FI76568C (fi) 1988-11-10
JPH0261458B2 (fr) 1990-12-20
NO155884C (no) 1987-06-17
IL64922A0 (en) 1982-04-30
DK158351B (da) 1990-05-07
AU8014482A (en) 1982-08-12
USRE32400E (en) 1987-04-14
DK630786D0 (da) 1986-12-29
NO155884B (no) 1987-03-09
HU187564B (en) 1986-01-28
JPS57149273A (en) 1982-09-14
ATE10192T1 (de) 1984-11-15
FI820140L (fi) 1982-08-06
NO820340L (no) 1982-08-06
FI76568B (fi) 1988-07-29
GB2092569B (en) 1984-09-19
EP0058047B1 (fr) 1984-11-07
EP0058047A1 (fr) 1982-08-18
CA1176259A (fr) 1984-10-16
DK630786A (da) 1986-12-29

Similar Documents

Publication Publication Date Title
DD210451A1 (de) Verfahren zur herstellung von imidazolderivaten
DD207713A1 (de) Substituierte imidazolabkoemmlinge, ihre herstellung und verwendung
DD200371A5 (de) Verfahren zur herstellung von 2,4-disubstituierten thiazolen
DE1493955B2 (de) Sulfonanilide und verfahren zu ihrer herstellung
CH630077A5 (de) Verfahren zur herstellung neuer tertiaerer imidazolylalkohole.
EP0011768B1 (fr) Hydroxypropyl triazoles, procédé pour leur préparation et médicaments contenant ces composés
DD148219A5 (de) Verfahren zur herstellung von hydroxyethyl-azolen
DE2461604C2 (fr)
DD267728A5 (de) Verfahren zur herstellung von arylcyclobutylalkylamin-derivaten
CH678852A5 (fr)
DE68905171T2 (de) Benzol-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die diese enthalten.
DE2130673A1 (de) Diphenylmethylimidazole,Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
DE1695189A1 (de) Verfahren zur Herstellung von Imidazolderivaten
DE2841644C2 (fr)
DE2619617C2 (fr)
DE3780438T2 (de) N-substituierte cyclische amine, ihre herstellung sowie pharmazeutische zusammensetzungen die sie enthalten.
DE2354931C2 (de) trans-2-Phenylbicyclooctan-Verbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE3876546T2 (de) Ethanon-oxime.
DE1620596A1 (de) 5-(Aryloxymethyl)-2-oxazolidinthione und Verfahren zu ihrer Herstellung
EP0014996B1 (fr) Spiro-amidines hétérocycliques, leurs stéréoisomères et isomères optiques, procédés pour leur préparation et médicaments les contenant
DE2539941C2 (de) Basische Benzyloxyalkyl-Derivate, deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE862602C (de) Verfahren zur Herstellung von Halogendiamidinen und ihren Salzen
EP0004260A1 (fr) Dérivés quinolizidiniques et indolizidiniques substitués, leur procédé de préparation et médicaments les contenant
EP0281121A1 (fr) 1-(1-Aryl-2-hydroxy-éthyl)-imidazoles et leurs sels, leurs procédés de préparation, médicaments contenant ces substances et leur utilisation
DE69209242T2 (de) 2-(3-Phenylpropyl)hydrazine, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung als Medikamente

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee